Intestinal Farnesoid X Receptor and Takeda G Protein Couple Receptor 5 Signaling in Metabolic Regulation. - Abstract - Europe PMC
Bile Acid Gut Microbiome Axis | News & Announcements | Cayman Chemical
Benefit of farnesoid X receptor inhibition in obstructive cholestasis | PNAS
Mechanisms of FXR regulation of enterohepatic circulation of bile acid.... | Download Scientific Diagram
![PDF] The role of FXR in disorders of bile acid homeostasis. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/23076a3fc4cab737803e720f5a4796195ab330ca/4-Figure1-1.png "PDF] The role of FXR in disorders of bile acid homeostasis. | Semantic Scholar")
PDF] The role of FXR in disorders of bile acid homeostasis. | Semantic Scholar
Effects of Bile Acids and the Bile Acid Receptor FXR Agonist on the Respiratory Rhythm in the In Vitro Brainstem Medulla Slice of Neonatal Sprague-Dawley Rats | PLOS ONE
Insights on FXR selective modulation. Speculation on bile acid chemical space in the discovery of potent and selective agonists | Scientific Reports
FXR - Intercept Pharmaceuticals
Role of farnesoid X receptor and bile acids in alcoholic liver disease - ScienceDirect
FXR: a metabolic regulator and cell protector | Cell Research
Cells | Free Full-Text | Why Bile Acids Are So Important in Non-Alcoholic Fatty Liver Disease (NAFLD) Progression
Bile Acid Receptor Farnesoid X Receptor: A Novel Therapeutic Target for Metabolic Diseases
Bile acid metabolism and signaling in liver disease and therapy - ScienceDirect
Don't Know Much Bile-ology”: Cell
Frontiers | Bile Acids and FXR: Novel Targets for Liver Diseases
Bile acid treatment and FXR agonism lower postprandial lipemia in mice | American Journal of Physiology-Gastrointestinal and Liver Physiology
Frontiers | Bile Acids and FXR: Novel Targets for Liver Diseases
Cells | Free Full-Text | Farnesoid X Receptor as Target for Therapies to Treat Cholestasis-Induced Liver Injury
MECHANISMS IN ENDOCRINOLOGY: FXR signalling: a novel target in metabolic diseases in: European Journal of Endocrinology Volume 184 Issue 5 (2021)
JCI - Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c
Bile acids and their receptors: modulators and therapeutic targets in liver inflammation | SpringerLink
Discovery and Optimization of Non-bile Acid FXR Agonists as Preclinical Candidates for the Treatment of Nonalcoholic Steatohepatitis | Journal of Medicinal Chemistry
